We are live on ! Find out more
NRXPW

NRX Pharmaceuticals Warrant
NRXPW

Delisted

NRXPW was delisted on the 22nd of May, 2026.

Back to rankings

15 hedge funds and large institutions have $934K invested in NRX Pharmaceuticals Warrant in 2018 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

12% more capital invested

Capital invested by funds: $835K → $934K (+$99K)

6% less funds holding

Funds holding: 16 → 15 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
15
Holders Change
-1
Holders Change %
-6.25%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
LIM
Longfellow Investment Management
Massachusetts
+$25.7K
2
RCM
Rivernorth Capital Management
Florida
+$13.6K
3
CI
Cowen Inc
New York
+$1.63K

Top Sellers

Rank Fund Capital Flow
1
BCM
Basso Capital Management
Connecticut
-$4K
Name Holding Trade Value Shares
Change 		Change in
Stake
BFM
1
Boothbay Fund Management
New York
$342K – – –
PAMP
2
Polar Asset Management Partners
Ontario, Canada
$83K – – –
VAS
3
VR Advisory Services
Cayman Islands
$72K – – –
RCM
4
Rivernorth Capital Management
Florida
$54K +$13.6K +29,958 +33%
WCMNY
5
Westchester Capital Management (New York)
New York
$51K – – –
BI
6
Bulldog Investors
New Jersey
$47K – – –
OAM
7
Oxford Asset Management
United Kingdom
$47K – – –
AA
8
AQR Arbitrage
Connecticut
$45K – – –
PC
9
Periscope Capital
Ontario, Canada
$42K – – –
6CM
10
683 Capital Management
New York
$37K – – –
YCM
11
Yakira Capital Management
Connecticut
$34K – – –
KPF
12
K2 Principal Fund
Ontario, Canada
$31K – – –
LIM
13
Longfellow Investment Management
Massachusetts
$25K +$25.7K +56,500 New
GCL
14
Glazer Capital LLC
New York
$15K – – –
CI
15
Cowen Inc
New York
$9K +$1.63K +3,567 +22%
BCM
16
Basso Capital Management
Connecticut
– -$4K -10,000 Closed

NRXPW Hedge Fund Activity: Q3 2018 in Review

15 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in NRX Pharmaceuticals Warrant (NRXPW) for Q3 2018, worth a combined $934K — up 12% from $835K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of NRXPW and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 2 added.

The largest buyer was Longfellow Investment Management, opening a new position worth an estimated $25.7K. The largest seller was Basso Capital Management, exiting entirely with an estimated $4K sold.

  • 15 institutional investors held NRX Pharmaceuticals Warrant (NRXPW) as of Q3 2018, down from 16 in Q2 2018.
  • Funds reported $934K of NRX Pharmaceuticals Warrant stock for Q3 2018, up 12% quarter-over-quarter.
  • 1 fund opened new NRX Pharmaceuticals Warrant positions in Q3 2018 and 2 closed out, a net change of -1 holder.
  • The largest NRX Pharmaceuticals Warrant buyer in Q3 2018 was Longfellow Investment Management, an estimated $25.7K added.
  • The largest NRX Pharmaceuticals Warrant seller in Q3 2018 was Basso Capital Management, an estimated $4K sold.

Based on aggregated 13F filings for Q3 2018.